4-methoxyfuro[3,2-g]chromen-7-one;4-methoxy-7-furo[3,2-g]chromenone;484-20-8;Spectrum2_000534;KBio2_006410;BSPBio_002325;NCGC00091582-01;ACon0_000984;KBio2_003842;SDCCGMLS-0066492.P001;IDI1_000529;NCGC00091582-02;AIDS-031096;ST057259;Oprea1_562364;AIDS031096;SPECTRUM300546;InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H;SPBio_000547;Spectrum5_000155;NSC95437;Spectrum3_000663;NINDS_000529;4-Methoxy-furo[3,2-g]chromen-7-one;ZINC00057731;4-methoxy-7H-furo[3,2-g]chromen-7-one;BAS 00674110;NCGC00017357-01;7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-;5-Methoxyfuranocoumarin;5-Methoxypsoralen;Bergapten;C01557;O-Methylbergaptol;KBio3_001545;KBio2_001274;TNP00299;275727_ALDRICH;4-Methoxyfuro[3,2-g]benzopyrane-7-one;DivK1c_000529;4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one;5-19-06-00004 (Beilstein Handbook Reference);5-Methoxy psoralen;5-Methoxy-6,7-furanocoumarin;5-Methoxypsoralen with ultraviolet A therapy;5-Mop;6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone;7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-;BERGAPTAN;BRN 0019560;Bergapten(e);Bergaptene;CCRIS 4348;EINECS 207-604-5;HSDB 3466;Heraclin;Majudin;NSC 95437;Psoraderm;65320_FLUKA;KBio1_000529;NCI60_042121;ACon1_001979;NCGC00091582-03;KBioSS_001274;Spectrum4_001478;Spectrum_000794;KBioGR_002055;MEGxp0_000990
4-methoxyfuro[3,2-g]chromen-7-one